Methods for treating inflammatory disorders
AssigneeThe Brigham and Women's Hospital, Inc.
InventorJoshua A. Boyce
Life of this patent
Estimating the term…
Abstract
The invention described herein is based, in part, on the discovery that thieno[3,2-c] pyridine derivatives prevent inflammation in the setting of inflammatory disorders, such as asthma. Described herein are methods for treating inflammatory disorders including, for example asthma, by administering a thieno[3,2-c] pyridine derivative compound to an individual in need thereof.
Claims6
A method of treating aspirin-exacerbated respiratory disease (AERD) in a subject, the method comprising administering to a subject having AERD a therapeutically effective amount of a compound having the formula:
- in which Y represent hydroxyl, an OR group wherein R is a straight or branched lower aklyl radical, or
- in which R1 and R2 are each independent of each other and represent hydrogen or a straight or branched lower alkyl group;
- or R1 and R2 form together with the nitrogen atom to which they are attached a heterocycle, selected from the group consisting of pyrrolidino, pipieridino, morpholino, piperazino, N-lower alkyl piperazino;
- and X represents hydrogen, a halogen or a lower alkyl radical;
- and their addition salts with pharmaceutically acceptable mineral or organic acids if Y represents the group OR or
- or with mineral bases if Y represents OH, including both enantiomeric forms or their mixture.
A method for treating aspirin-exacerbated respiratory disease (AERD) in a subject, the method comprising administering to a subject having AERD a compound selected from the group consisting of dextro-rotatory isomer of methyl alpha-5(4,5,6,7-tetrahydro(3,2-c)thieno pyridyl) (2-chlorophenyl)-acetate substantially separated from the levorotatory isomer and its pharmaceutically acceptable salts, hydrochloride of the dextro-rotatory isomer of methyl alpha-5(4,5,6,7-tetrahydro(3,2-c)thieno pyridyl) (2-chlorophenyl)-acetate substantially separated from the levo-rotatory isomer, hydrogen sulfate of the dextro-rotatory isomer of methyl alpha-5(4,5,6,7-tetrahydro(3,2-c)thieno pyridyl) (2-chlorophenyl)-acetate substantially separated from the levo-rotatory isomer, hydrobromide of the dextro-rotatory isomer of methyl alpha-5(4,5,6,7-tetrahydro(3,2-c)thieno pyridyl) (2-chlorophenyl)-acetate substantially separated from the levo-rotatory isomer, and taurocholate of the dextro-rotatory isomer of methyl alpha-5(4,5,6,7- tetrahydro(3,2-c)thieno pyridyl) (2-chlorophenyl)-acetate substantially separated from the levo-rotatory isomer.
Dependencies are inferred from the claim text.